- Author:
Muhammad MIFTAHUSSURUR
1
Author Information
- Publication Type:Review
- From:Gut and Liver 2020;14(5):553-559
- CountryRepublic of Korea
- Language:0
- Abstract: Although the prevalence of Helicobacter pylori infection in Indonesia is lower than that in other countries, H. pylori is still an essential pathogen associated with severe gastric mucosal damage and dyspeptic symptoms. Invasive diag-nostic methods are not ideal due to the lack of endoscopic centers and high costs without full coverage by social insur-ance. Among the noninvasive methods, the urea breath test is widely available in Indonesia and has been suggested as the primary option to ensure the successful eradication of H.pylori. There has been no local validation for the urea breath test utilizing 13 C or 14 C. The stool antigen test is inexpensive and suitable for use in active infections before and after eradication; however, customs and habits are obstacles to delivering fresh stool on time. Only polyclonal antibodies and qualitative stool antigen test kits with low sensitivity are available. Serology is a widely validated method and has good accuracy, but it cannot distinguish between active and inactive infections. According to our observations, serology is the main choice of experts and patients, as it is simple, inex-pensive and widely known. The urine test is an alternative for reducing costs and endoscopic workload, with high accuracy but low sensitivity. Further studies are necessary to prove the validity of the urine test to be used throughout Indonesia, especially in areas with a low prevalence of H. pylori infec-tion. In conclusion, the validated urea breath test and the stool antigen test are considered noninvasive practical ap-proaches for the detection of H. pylori infection in Indonesia, with serological and urine tests as alternatives.